The i.c.v. infusion of ALS-CSF caused dramatic changes in levels of IF proteins with severe downregulation of neurofilament proteins (NfL, NfM, and InA) and upregulation of type III IF proteins peripherin and GFAP. The gene discussed is GFAP; the disease is amyotrophic lateral sclerosis.